ALNY
Alnylam Pharmaceuticals, Inc. · Healthcare
CEO John Maraganore sold $2.0M of Alnylam Pharmaceuticals, Inc.
Sold$2,033,972
$67.46Price
30,151Shares
−18%Stake
What ALNY did after the filing
- The stock from Tue, Sep 6 open, $69.54
- −45.3%
- S&P 500, same days
- −1.8%
Measured over 30 trading days, to the Oct 18 close.
Traded Tue, Apr 19. Filed Thu, Apr 21, 5:01 PM ET, after the close. Returns use the Sep 6 open and the Oct 18 close. Not investment advice.